Xuemei Gu, Rui Sun, Liang Chen, Shenghui Chu, Mark A. Doll, Xiaohong Li, Wenke Feng, Leah Siskind, Craig J. McClain, Zhongbin Deng – 13 November 2020
Lisa Hernandez Sampere, Johannes Vermehren, Victoria T. Mücke, Christiana Graf, Kai‐Henrik Peiffer, Georg Dultz, Stefan Zeuzem, Oliver Waidmann, Natalie Filmann, Joerg Bojunga, Christoph Sarrazin, Mireen Friedrich‐Rust, Marcus M. Mücke – 12 November 2020 – Chronic viral hepatitis is associated with substantial morbidity and mortality worldwide.
Shalom Z. Frager, James Szymanski, Jonathan M. Schwartz, Hatef S. Massoumi, Milan Kinkhabwala, Allan W. Wolkoff – 11 November 2020 – The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS‐CoV2) is the causative agent of coronavirus disease 2019 (COVID‐19). The presenting symptoms of this virus are variable, and there is an increasing body of literature on risk factors for mortality.
Rohit Loomba – 11 November 2020
Vik Meadows, Heather Francis – 11 November 2020
Jeffrey S. Morris, Manal Hassan, Hesham Amin, Ahmed Kaseb – 10 November 2020
Lejia Sun, Ai Guan, Meixi Liu, Yilei Mao – 10 November 2020
Jeffrey S. Morris, Manal Hassan, Hesham Amin, Ahmed Kaseb – 10 November 2020
Teh‐Ia Huo, Po‐Hong Liu, Chia‐Yang Hsu – 10 November 2020
Arpan A. Patel, Aileen Bui, Eian Prohl, Debika Bhattacharya, Su Wang, Andrea D. Branch, Ponni V. Perumalswami – 10 November 2020 – New therapies offer hope for a cure to millions of persons living with hepatitis C virus (HCV) infection. HCV elimination is a global goal that will be difficult to achieve using the traditional paradigms of diagnosis and care. The current standard has evolved toward universal HCV screening and treatment, to achieve elimination goals. There are several steps between HCV diagnosis and cure with major barriers along the way.